Finch Therapeutics Group, Inc.
(NASDAQ : FNCH)

( )
FNCH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
TDOCTeladoc Health, Inc. -8.74%35.408.2%$199.35m
ONEM1Life Healthcare, Inc. 0.06%16.850.0%$151.69m
DVADaVita, Inc. 0.93%89.304.1%$76.24m
NTRANatera, Inc. -2.57%50.821.1%$70.01m
OSHOak Street Health, Inc. -2.27%29.280.0%$59.23m
AGLAgilon Health, Inc. -2.66%26.350.0%$58.53m
DNAGinkgo Bioworks Holdings, Inc. -3.55%3.130.0%$54.45m
GHGuardant Health, Inc. -10.17%48.960.0%$51.17m
AMEDAmedisys, Inc. -3.05%119.4811.4%$51.15m
ACHCAcadia Healthcare Co., Inc. -1.85%79.5926.6%$48.46m
EHCEncompass Health Corp. -2.12%51.680.0%$44.47m
LHCGLHC Group, Inc. 0.49%162.603.0%$42.98m
AZTAAzenta, Inc. -7.48%63.850.0%$39.34m
OPCHOption Care Health, Inc. -1.55%34.370.0%$37.51m
PRVAPrivia Health Group, Inc. -2.41%36.800.0%$30.44m

Company Profile

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Somerville, MA.